Some of Imperial's current research in the areas of health management are outlined below.
Incentive and Payment
Dr Marissa Miraldo
Dr Miraldo is particularly interested in regulation and policy evaluation in the health care sector and, more generally, in the public sector as well on the role of economic preferences on health and healthcare related decision-making.
Recent research output includes the determinants of successful pharmaceutical Research and Development, a comparative analysis of different drug reimbursement systems, the impact of different reimbursement systems on the development and adoption of new technologies, analysis on the pharmaceutical firms strategic responses to drug reimbursement policies, optimal contracts with asymmetric information and different contractual arrangements within the hospital and the link of health habits (e.g. overeating and smoking) and economic behaviour.
Innovation and Organisational Change in Healthcare
James Barlow holds a Chair in Technology and Innovation Management at Imperial College Business School. His work focuses on the adoption, implementation and sustainability of innovation in healthcare. He is especially interested in the relationships between services, technologies and infrastructures within the highly complex, rapidly changing environment for healthcare. This includes extensive work on the development and introduction of 'remote care' such as telehealth/telecare, and on the use of public-private partnerships (PPPs) for delivering healthcare infrastructure.
He was the Principle Investigator of HaCIRIC – the Health and Care Infrastructure Research and Innovation Centre from 2006 to 2013. He is currently Associate Director of Research and Evaluation for Imperial College Health Partners and in 2014 was appointed President of the International Academy of Design and Health. James has worked with many companies and organisations involved in healthcare, and has sat on advisory panels on healthcare innovation around the world.
Clinical Trials Unit (ICTU)
Professors Deborah Ashby and Neil Poulter
The Imperial Clinical Trials Unit helps to develop and test new healthcare interventions, drugs and therapies to the highest scientific standards. ICTU builds on Imperial’s reputation in both research and teaching and its recognised expertise and key opinion leaders, to deliver high quality research. The results of this research increase our understanding of healthcare provision and treatment of disease both within the UK and internationally, helping to answer key scientific and healthcare questions for the benefit of current and future patients.
Dr Lesong Conteh
Dr Conteh is a health economist in the School of Public Health. Her research interests include: coordinating multi-country economic evaluations to identify the costs, cost effectiveness and equity implications of introducing interventions via different delivery strategies; understanding the market for community health workers, and; investigating consumer and provider interpretations of quality in the delivery of health care.
She is currently involved in 3 main areas of research:
- Multi-country economic evaluations in West Africa exploring the delivery of interventions via community health workers.
- Understanding if and how notions of perceived quality have changed over the last decade in The Gambia amid changes to malaria treatment. Furthermore, if consumer and provider notions of good quality malaria treatment have not only changed over time, but if they have changed in similar ways.
- Exploring how providers attempt to signal the quality of their services to consumers. This project aims to investigate if and how providers respond to any shifting perceptions of quality among consumers and specifically, do providers identify a need to change how they promote the quality of their malaria treatment as good?
She collaborates with a number of African, European and American academic institutions and International Development partners.
Centre for Patient Safety and Service Quality (CPSSQ)
The Centre for Patient Safety and Service Quality (CPSSQ) is a partnership between Imperial College Healthcare NHS Trust (ICHT) and Imperial. It brings together researchers from a range of clinical and scientific fields aimed at improving quality and safety. The Centre has quickly gained international recognition since its inception in 2007 and was awarded an additional £7.2M by the NIHR to be one of only two UK Patient Safety Translational Research Centres. Researchers within the centre have expertise in surgery, medicine, pharmacy, infection prevention, psychology, economic evaluation, technological innovation, organisational development and patient involvement. Close links between academic research and clinical services help with the translation of research findings into patient care, and ensures that research is clinically relevant. All healthcare professionals want their patients to have safe care; the CPSSQ aims to contribute to this, both at ICHT and in the wider NHS.
The Centre is currently undertaking 8 research themes, including Infection Prevention and Management, Medication Safety, Safe Systems, Design and Technology and Use of Information as safety indicators and safety ‘intelligence’.
Lifelong Health Project
Professor Maggie Dallman
The ageing population is bringing with it a number of challenges. The unprecedented increase in the number of elderly has many repercussions for financial, social and medical aspects of day-to-day life.
Population ageing represents a global challenge and although the increased life expectancy symbolises a scientific success story, it brings with it fresh new challenges.
Ageing represents a highly fitting theme for a multidisciplinary research programme, and here at Imperial College we are engaging in a breadth of ageing research, from pensions to tissue engineering, through to neurodegenerative diseases, biosensors and personal mobility. The Lifelong Health Project brings together world-class research teams from the Faculties of Engineering, Medicine and Natural Sciences, and the Business School, helping to catalyse cutting-edge high impact research and allowing Imperial College to contribute to this high priority area in a very diverse way.
WHO Collaborating Centres for Public Health Education and Training
Professor Salman Rawaf
The World Health Organisation Collaborating Centre for Pu blic Health Educat ion and Training was designated in June 2007. Supported by the British Government, the Collaborating Centre sits within the Department of Primary Care & Public Health (School of Public Health) at Imperial College London. The Centre is based at Charing Cross Hospital in West London.
The Centre, based at Charing Cross Hospital in West London, is currently involved in many public health training and educational activities in UK and internationally in all six WHO Regions. The Centre provides technical support to strengthen countries health sys tems through system reviews, hu man resource for health development and capacity building. T he WHO Collaborating Centre expert team has extensive links worldwide and is engaged in wide range of activities to achieve its mission.
Their mission is simple. They support the work of the World Health Organisation and its founding objective, namely: the attainment by all peoples of the highest possible level of health.
Contact: Ela Augustyniak email@example.com +44(0)20 7594 8603
National Centre for Infection Prevention and Management (CIPM)
Professor Jon Friedland and Professor Alison Holmes
The National Centre for Infection Prevention and Management (CIPM) is tackling the issue of healthcare associated infection, including antibiotic resistance, via a multidisciplinary approach that includes organizational research, social marketing, epidemiology, laboratory-based programmes and education. The Centre has four main themes or work-streams:
Innovation Adoption & Behaviour Change: this theme addresses the implementation gap between research and its use in the NHS and seeks to identify strategies for effective and sustainable change in antibiotic prescribing and infection control behaviours. This theme will deliver guidelines and briefs on how to diagnose factors which prevent or hinder the adoption of new technologies or patterns of working within the NHS and will assess the value of using social marketing principles in changing behaviours.
Network in Clinical Infection & Diagnostics: through its laboratory programme and collaboration with the Centre for Infections, PHE, this theme will identify whether some features of Staphylococcus aureus, Streptococcus pyogenes, and Clostridium difficile strains make them more invasive and transmissible than others. It may deliver novel diagnostic tools.
Infection Surveillance: is using existing databases within Imperial College Healthcare NHS Trust, the NHS, PHE and elsewhere to develop predictive models, which will enable identification of at risk patients and effectively direct early intervention. Through evaluating systems to monitor antibiotic resistance and prescribing practice, it will also provide information about front line antibiotic management decisions in support of antimicrobial policies.
Capacity Building: has developed a range of educational courses and training. These will aim to develop a specifically skilled academic, clinical scientific and medical workforce to deliver clinical care, research and leadership in infection prevention.
Public Health Policy Evaluation
Research in this area includes a growing focus on evaluating strategies to prevent and manage chronic (non-communicable) disease in low and middle income country settings, particularly in India, the country that is expected to experience more cardiovascular deaths than any other over the next decade.
The main areas of research currently being conducted include: tobacco control, active travel, improving the management of chronic disease and financial protection in health systems.